Key result
A patient-tailored, pharmacist-led intervention program did not significantly improve self-reported adherence to antihypertensive medication compared to usual care (mean difference 0.18).
Why the study?
Does a patient-tailored, pharmacist-led intervention program improve self-reported medication adherence in non-adherent patients taking antihypertensive medication?
RCT (n=170)
Open-label
1:1
Yes
Does a patient-tailored, pharmacist-led intervention program improve self-reported medication adherence in non-adherent patients taking antihypertensive medication?
Effect estimate: Mean difference 0.18 (95% CI -0.27 to 0.63)
p-value: p=0.440
A patient-tailored, pharmacist-led intervention program did not significantly improve self-reported medication adherence or blood pressure in patients non-adherent to antihypertensive therapy.
No takes yet. Share an insight, caveat, or question.
Does not support patient-tailored pharmacist interventions for antihypertensive adherence; challenges equivocal prior evidence and directs research toward alternatives.
Laan et al. (2018) conducted an RCT in Hypertension with medication non-adherence (n=170). Patient-tailored, pharmacist-led intervention program (CATI) vs. Usual care was evaluated on Self-reported medication adherence (MARS-5 sum score) (Mean difference 0.18, 95% CI -0.27 to 0.63, p=0.440). A patient-tailored, pharmacist-led intervention program did not significantly improve self-reported adherence to antihypertensive medication compared to usual care (mean difference 0.18).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: